Read the screenplay: FANNIEGATE — $7 trillion. 17 years. The biggest fraud in American capital markets.
#96
#96

Cyrus Poonawalla

India

Net Worth

$10B

Source of Wealth

Serum Institute of India

Global Rank

#96 of 100

About Cyrus Poonawalla

Cyrus Poonawalla is the founder of the Serum Institute of India, the world's largest vaccine manufacturer by number of doses produced, and a towering figure in global public health. Under his leadership, the Serum Institute has produced billions of vaccine doses that have protected children and adults in over 170 countries, saving millions of lives and making affordable immunization accessible to the developing world. His vision of producing high-quality vaccines at prices that even the poorest nations could afford has had an immeasurable impact on human welfare.

Poonawalla founded the Serum Institute in 1966 in Pune, India, with the goal of manufacturing life-saving immunizations for diseases that disproportionately affected developing countries. Starting with anti-tetanus serum, the company gradually expanded its capabilities to produce vaccines for measles, polio, influenza, hepatitis, and numerous other diseases. The Serum Institute's ability to produce vaccines at a fraction of the cost charged by Western pharmaceutical companies — while maintaining rigorous quality standards approved by the World Health Organization — revolutionized global immunization and made it possible for international organizations like UNICEF to dramatically expand their vaccination programs.

The Serum Institute's role during the COVID-19 pandemic further cemented its importance to global health. As the primary manufacturer of the Oxford-AstraZeneca vaccine for developing countries, the Serum Institute produced over a billion doses under the Covishield brand, playing an indispensable role in the global vaccination effort. Poonawalla's decades of investment in manufacturing capacity and quality systems positioned the company to respond at a scale that no other manufacturer could match, and his commitment to equitable access helped ensure that vaccines reached populations that might otherwise have been left behind.

Key Achievements

World's Largest Vaccine Manufacturer

Built the Serum Institute of India into the world's largest vaccine manufacturer by doses, producing over 1.5 billion doses annually and supplying over 170 countries.

Billions of Lives Protected

Produced billions of affordable vaccine doses over five decades, immunizing an estimated 65% of the world's children and preventing countless deaths from preventable diseases.

COVID-19 Vaccine Production

Manufactured over a billion doses of Covishield (Oxford-AstraZeneca) COVID-19 vaccine, making the Serum Institute indispensable to the global pandemic response.

Affordable Healthcare Pioneer

Demonstrated that high-quality, WHO-approved vaccines could be manufactured and distributed at prices affordable to developing nations, transforming global immunization economics.

Notable Quotes

Our mission has always been simple: produce the best possible vaccines and make them affordable enough that every child in the world can be protected.

Cyrus Poonawalla

Health should never be a privilege of the wealthy. Vaccines are the most cost-effective tool humanity has to prevent suffering, and they should be available to all.

Cyrus Poonawalla

When you see the impact of immunization on children's lives, you understand why this work is the most meaningful thing anyone can do.

Cyrus Poonawalla

Key Decisions

1966

Founded the Serum Institute of India in Pune with the mission of manufacturing affordable, high-quality vaccines for the developing world.

1980s

Secured World Health Organization prequalification for the Serum Institute's vaccines, opening the door to supply contracts with UNICEF and other global health organizations.

2000s

Invested heavily in expanding manufacturing capacity, positioning the Serum Institute to become the world's largest vaccine producer by volume.

2019

Began transitioning day-to-day leadership to son Adar Poonawalla while maintaining strategic oversight as the company prepared for its largest-ever production challenges.

2020

Committed the Serum Institute to produce over a billion doses of COVID-19 vaccine at cost for developing countries, making it the backbone of the global COVAX initiative.

Early Life

Cyrus Poonawalla was born in 1941 in Pune, India, into a family that bred racehorses — his father was a prominent horse racing enthusiast and stud farm owner. Young Cyrus initially showed more interest in horses than in science or industry. However, in the 1960s, he noticed that the government-run Haffkine Institute was discarding horses after using them to produce sera (the horses were injected with pathogens to produce antibodies, which were then extracted for medical use). Poonawalla had the entrepreneurial insight that he could acquire these retired horses cheaply, continue extracting sera from them, and produce vaccines at a fraction of the cost charged by government manufacturers. In 1966, at age 25, he founded the Serum Institute of India with this simple but powerful business model. What began as an opportunistic venture by a horse breeder would grow into the world's largest vaccine manufacturer by number of doses produced.

Companies & Ventures

Serum Institute of India

Chairman & Managing Director · Est. 1966

The Serum Institute of India is the world's largest vaccine manufacturer by number of doses produced, manufacturing over 1.5 billion doses annually and supplying vaccines to approximately 170 countries. The company produces vaccines for polio, measles, mumps, rubella, diphtheria, tetanus, pertussis, hepatitis B, influenza, and numerous other diseases at some of the lowest prices in the world. During the COVID-19 pandemic, the Serum Institute was the world's largest producer of the AstraZeneca-Oxford vaccine (marketed as Covishield in India), playing a critical role in the global vaccination effort.

1.5B+ vaccine doses produced annuallySupplies 170+ countries65% of world's children receive at least one SII vaccineLargest COVID-19 vaccine producer globally (by volume)

Philanthropy

Cyrus Poonawalla has donated billions of rupees to healthcare, education, and community development in India. His philanthropy is deeply intertwined with his business — by producing vaccines at the lowest possible cost, the Serum Institute has effectively provided an ongoing philanthropic service to the developing world, where affordable vaccines have saved millions of lives. Beyond his business contributions, Poonawalla has personally funded hospitals, medical research centers, and educational institutions in Pune and across Maharashtra. His son Adar Poonawalla has continued this tradition, making major donations to clean city initiatives and public health campaigns. The Poonawalla family's approach to philanthropy reflects a belief that the greatest charitable contribution a business can make is to produce essential products affordably enough that even the poorest populations can access them.

Explore More

See how Glen Bradford applies these principles to his own investing. Long Fannie Mae & Freddie Mac junior preferred — and not going anywhere.